My Japanese aunt turned 100 years old this year, and for as long as I can remember, she’s always been a graceful and elegant ...
Barry Ritholtz’s new book discusses why most people are bad at investing, and why famous investors who consistently beat the ...
The personal consumption expenditures price index was expected to increase 0.3% in February while spending was projected to ...
King Charles III smiled and waved to members of the public Friday, a day after a brief hospitalization for the side effects ...
U.S. activist investor Elliott Investment Management has taken a short position against British oil major Shell as part of a ...
Ubisoft shares surged on Friday after the French video game publisher announced a deal to spin out some of its best-selling ...
Russian President Vladimir Putin warned it would be foolish to dismiss U.S. President Donald Trump’s push for control over ...
European stocks opened lower on Friday as global markets braced for U.S. President Donald Trump’s latest tariffs on ...
U.S. Treasury yields moved lower on Friday morning, as President Trump’s tariffs regime and the broader state of the economy ...
Barbara Corcoran has been a successful entrepreneur and investor for years. The relationship that’s helped her the most: the one with her mom.
Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.
CoreWeave CEO Mike Intrator said on “Squawk Box” that the company had to “rightsize” its pricing ahead of the Friday IPO.